Journal article

Novel biotherapies are needed in youth mental health

G Paul Amminger, M Berger, SM Rice, CG Davey, MR Schäfer, PD McGorry

Australasian Psychiatry | Published : 2017

Abstract

Adverse effects and lack of efficacy in a significant number of patients limit pharmaceutical interventions in youth psychiatry. This is exemplified by the fact that no medication is currently approved for the treatment of non-OCD anxiety disorders or major depressive disorder in young people younger than 18 years of age in Australia. Here, emerging biological therapies for youth with mental health problems are discussed. There is an urgent need for more research into biological interventions with acceptable risk-benefit balances. Omega-3 fatty acids, cannabidiol and N-acetylcysteine are currently being evaluated. If initial findings are confirmed, they may offer alternatives with more benig..

View full abstract

Grants

Awarded by Royal Melbourne Hospital


Funding Acknowledgements

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: G.P.A. was supported by National Health and Medical Research Council Australia (NHMRC) Senior Research Fellowship (ID:1080963); M.B. was supported by a JCU Postgraduate Research Scholarship; S.M.R. was supported by the Mary Elizabeth Watson Early Career Fellowship in Allied Health from the Royal Melbourne Hospital, Australia; C.D. was supported by an NHMRC Career Development Fellowship (1061757); P.D.M. was supported by NHMRC Senior Principal Research Fellowship (ID: 1060996)